Long-Covid Patients Are Frustrated That Federal Research Hasn't Found New Treatments
Long-Covid Patients Are Frustrated That Federal Research Hasn't Found New Treatments
![](https://lemdro.id/pictrs/image/bbee8b9b-163a-4dff-8294-bce87bb5a3f2.jpeg?format=webp&thumbnail=128)
The federal government has allocated $1.15 billion to long-covid research without any new treatments yet brought to market. Patients and scientists say it’s time to push harder for breakthroughs.
![Long-Covid Patients Are Frustrated That Federal Research Hasn't Found New Treatments - KFF Health News](https://lemdro.id/pictrs/image/bbee8b9b-163a-4dff-8294-bce87bb5a3f2.jpeg?format=webp)
Along with claiming the lives of 1.2 million Americans, the covid-19 pandemic has been described as a mass disabling event.
Estimates of prevalence range considerably, depending on how researchers define long covid in a given study, but the Centers for Disease Control and Prevention puts it at 17 million adults.
Despite long covid’s vast reach, the federal government’s investment in researching the disease — to the tune of $1.15 billion as of December — has so far failed to bring any new treatments to market.